GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Spineway ALSPW.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.10

0.00%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Spineway

Its shares trade on Euronext Paris under the ticker ALSPW.PA. It has been listed since 8 February 2013. In the fiscal year to 31 December 2025, it reported revenue of €12.4m and a net loss of €2.2m. At that date it held total assets of €29.5m and shareholders' equity of €23.1m.

Spineway SA is engaged in the design, production, and sale of spinal column implants and surgical instruments. The company is headquartered in Ecully, Auvergne-Rhone-Alpes. The company went IPO on 2013-02-08. The company designs, produces and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, among others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
8 Feb 2013
Employees
35

Leadership

Pay as last reported

  • Mr. Stephane Le RouxChairman of the Board, Chief Executive Officer, since 2012
  • Ms. Sandrine CarleDeputy Chief Executive Officer
  • Mr. Erwan MartinChief Financial Officer
  • Ms. Sophie BaratteDirector
  • Ms. Berangere Colette BoggioDirector
  • Mr. Joseph Paul-Henry BrigneaudDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Spineway SA designs, produces, and sells spinal column implants and surgical instruments.
  • The company has a focused product range including spinal systems, cervical and lumbar cages, and cervical plates.
  • Spineway SA has been publicly traded since its IPO on 2013-02-08.

Weaknesses

  • The company employs only 35 full-time employees.
  • Spineway SA is headquartered in Ecully, Auvergne-Rhone-Alpes, which may limit market reach.
  • The company's product range is limited to spinal column implants and surgical instruments.

Opportunities

  • Spineway SA could expand its product range beyond spinal column implants and surgical instruments.
  • The company may grow by targeting new markets outside its current geographic location.
  • Spineway SA could leverage its IPO status to attract more investment for expansion.

Threats

  • Spineway SA faces competition in the spinal implant market from larger companies.
  • The company's small employee count may hinder its ability to scale operations.
  • Spineway SA's reliance on a narrow product range exposes it to market fluctuations in the spinal implant sector.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.